In the current Clinical Trials Directive, the definition of conditions for inclusion of vulnerable populations is limited to clinical trials with minors and incapacitated adults who are not able...
Health-related Quality of Life (HRQoL) measures provide important information about the added value of a health technology and are often used to support decision-making in Health Technology Assessment (HTA)...
How early in the development of a new medicine should thEarly collaboration - a recipe for solutions: drug development and treatment strategies may go hand in hand.e discussion between...
An example of patients involved through patients and patient organisations providing input into a
Cushing’s disease clinical trial design. The consultation took place between Novartis and nurses from different teams...
HTA is a multidisciplinary process that examines the information about medical, cost-effectiveness, social, political, legal and ethical considerations of the application of a health technology – usually a medicine,...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy